191 results on '"Miranda, Roberto N."'
Search Results
2. Clinical and pathological characteristics of HIV- and HHV-8–negative Castleman disease
3. The biology and treatment of plasmablastic lymphoma
4. CD19 CAR-T Outcomes in Patients with EBV-Positive DLBCL
5. Updated Results of an Investigator-Initiated Phase II Study of Pembrolizumab and Romidepsin for Patients with Relapsed or Refractory T-Cell Lymphoma (TCL) with Survival Analysis
6. Cutaneous/ Subcutaneous Involvement - an Immune privileged Site Associated with Poor Outcomes in Systemic Peripheral T/ NK Cell Lymphoma.
7. Clinical Outcomes of Patients with Breast Implant- Associated Anaplastic Large- Cell Lymphoma (BIA-ALCL) Treated with Chemotherapy and Brentuximab Vedotin
8. Integrated genomic sequencing reveals mutational landscape of T-cell prolymphocytic leukemia
9. Cutaneous/ Subcutaneous Involvement - an Immuneprivileged Site Associated with Poor Outcomes in Systemic Peripheral T/ NK Cell Lymphoma.
10. MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program
11. CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study
12. Transcription and translation are primary targets of Pim kinase inhibitor SGI-1776 in mantle cell lymphoma
13. Long Term Outcome Patterns and Risk Factors for Early Mortality and Disease Progression in ALK-Positive Anaplastic Large Cell Lymphoma
14. CD70 Expression in Mature T-Cell Lymphomas
15. Outcome of Patients with T- Cell Histiocyte Rich B Cell Lymphoma: Single Institution Series
16. Radiomic Phenotypes of High and Low Lesion SUV Components for the Prediction of Refractory Disease in Hodgkin's Lymphoma Patients Treated with ABVD Based Therapy
17. Outcomes of Patients with Extranodal Natural Killer/T-Cell Lymphoma: Single Institution Series
18. Real Life Treatment Alterations of Frontline Therapies in Classic Hodgkin's Lymphoma
19. Autologous Stem Cell Transplantation for Angioimmunoblastic T-Cell Lymphoma
20. A Phase II Study of Pembrolizumab in Combination with Romidepsin Demonstrates Durable Responses in Relapsed or Refractory T-Cell Lymphoma (TCL)
21. Retrospective Review of Prognostic and Predictors Markers in Newly Diagnosed Angioimmunoblastic T Cell Lymphoma at UT MD Anderson Cancer Center
22. Association of Smoking with Advanced Stage and Survival Outcomes in Classic Hodgkin's Lymphoma
23. Association of Epstein-Barr Virus with Advanced Stage and Survival Outcomes in Classic Hodgkin's Lymphoma
24. Association of Vitamin D Deficiency with Inferior Treatment Outcomes in Patients with Newly Diagnosed Classic Hodgkin Lymphoma: MD Anderson Cancer Center Experience
25. A Phase I/II Study to Examine the Safety and Efficacy of Pembrolizumab 200 Mg Fixed Dose Administered Every 3 Weeks (Q3W) in Combination with Romidepsin in Relapsed or Refractory Peripheral T-Cell Lymphoma (PTCL)
26. Maintenance Rituximab in Nodular Lymphocyte Predominant Hodgkin Lymphoma (NLPHL) in the First Line Setting or at Relapse
27. Gene Expression Profiling Using Nanostring™ Reveals Differences According to Location, Histology and MIPI Score in Mantle Cell Lymphoma
28. MYC Expression in Systemic Anaplastic Large Cell Lymphoma: Clinicopathologic and Prognostic Features of 70 Patients
29. Genetic subtyping of breast implant–associated anaplastic large cell lymphoma
30. Kikuchi-Fujimoto disease
31. A novel recurrent NPM1-TYK2 gene fusion in cutaneous CD30-positive lymphoproliferative disorders
32. The Risk of Central Nervous System (CNS) Relapses in Patients with Peripheral T-Cell Lymphoma
33. MYC Copy Number Aberrancies Predict a Worse Prognosis in Patients with Diffuse Large B-Cell Lymphoma
34. The Neutrophil-to-Lymphocyte Ratio Is Prognostic in Patients with Early Stage Peripheral T-Cell Lymphoma
35. The Survival Outcome of the Patients with Relapsed/Refractory PTCL-NOS and AITL
36. ONC201 Induces p53-Independent Apoptosis and Abrogates Stem Cell Function in Hematological Malignancies By Induction of ATF4 through Integrated Stress Response
37. MYC/BCL2 Double Hit Lymphoma: What Really Matters
38. The Survival Outcome of the Patients with Relapsed/Refractory Anaplastic Large-Cell Lymphoma
39. Integrated Genome Sequencing Reveals Frequent Loss of Function Alterations of ARID1A and Other Epigenetic Modifiers in Sezary Syndrome
40. ONC201 Induces p53-Independent Apoptosis and Cell Cycle Arrest in Hematological Malignancies and Leukemic Stem/Progenitor Cells By Inducing ER Stress and mTOR Inhibition
41. Novel Gene Translocations Involving TYK2 in Cutaneous CD30-Positive Lymphoproliferative Disorders
42. Radiation Therapy Significantly Improves Survival Of Patients With Diffuse Large B-Cell Lymphoma Associated With MYC Translocation: A Report From The International DLBCL Rituximab-CHOP Consortium Program
43. Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study
44. Prognostic Factors for Survival in 60 Patients with Classical Hodgkin Lymphoma From Peru
45. HIV-Associated Plasmablastic Lymphoma: A Multi-Institutional Study
46. The t(14;18)(q32;q21) Characterizes a Subset of Patients with Diffuse Large-B Cell Lymphoma of Germinal Center Origin with Poor Outcome: Report From the International DLBCL Rituximab-CHOP Consortium Program Study
47. Aberrant Expression of Golgin-84 in Non-Hodgkin Lymphomas and Plasma Cell Myeloma
48. A novel recurrent NPM1-TYK2gene fusion in cutaneous CD30-positive lymphoproliferative disorders
49. Evidence That Some Breast Implant Associated Anaplastic Large Cell Lymphomas Arise in the Context of Allergic Inflammation
50. MYCCopy Number Aberrancies Predict a Worse Prognosis in Patients with Diffuse Large B-Cell Lymphoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.